Literature DB >> 10072545

Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.

I Sabroe1, A Hartnell, L A Jopling, S Bel, P D Ponath, J E Pease, P D Collins, T J Williams.   

Abstract

To investigate eosinophil stimulation by chemokines we developed a sensitive assay of leukocyte shape change, the gated autofluorescence/forward scatter assay. Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell and are essential to the processes of leukocyte migration from the microcirculation into sites of inflammation. We examined the actions of the chemokines eotaxin, eotaxin-2, monocyte chemoattractant protein-1 (MCP-1), MCP-3, MCP-4, RANTES, macrophage inflammatory protein-1alpha (MIP-1alpha), and IL-8 on leukocytes in mixed cell suspensions and focused on the responses of eosinophils to C-C chemokines. Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent. Responses to MCP-4 were qualitatively different, showing marked reversal of shape change responses with agonist concentration and duration of treatment. In contrast, MIP-1alpha induced a potent response in eosinophils from a small and previously undescribed subgroup of donors via a non-CCR3 pathway likely to be CCR1 mediated. Incubation of leukocytes at 37 degrees C for 90 min in the absence of extracellular calcium up-regulated responses to MCP-4 and MIP-1alpha in the majority of donors, and there was a small increase in responses to eotaxin. MIP-1alpha responsiveness in vivo may therefore be a function of both CCR1 expression levels and the regulated efficiency of coupling to intracellular signaling pathways. The observed up-regulation of MIP-1alpha signaling via non-CCR3 pathways may play a role in eosinophil recruitment in inflammatory states such as occurs in the asthmatic lung.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072545

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

2.  Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors:  Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue.

Authors:  W Reid Bolus; Dario A Gutierrez; Arion J Kennedy; Emily K Anderson-Baucum; Alyssa H Hasty
Journal:  J Leukoc Biol       Date:  2015-05-01       Impact factor: 4.962

4.  IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.

Authors:  Michael P Nelson; Benjamin S Christmann; Jessica L Werner; Allison E Metz; Jennifer L Trevor; Clifford A Lowell; Chad Steele
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

5.  CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism.

Authors:  Patricia C Fulkerson; Hongyan Zhu; David A Williams; Nives Zimmermann; Marc E Rothenberg
Journal:  Blood       Date:  2005-03-31       Impact factor: 22.113

6.  Human eosinophils express functional CCR7.

Authors:  Praveen Akuthota; Shigeharu Ueki; Jessica Estanislau; Peter F Weller
Journal:  Am J Respir Cell Mol Biol       Date:  2013-06       Impact factor: 6.914

7.  Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation.

Authors:  Ping Ling; Karen Ngo; Steven Nguyen; Robin L Thurmond; James P Edwards; Lars Karlsson; Wai-Ping Fung-Leung
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

8.  Nitric oxide regulates neutrophil migration through microparticle formation.

Authors:  Sarah Nolan; Rachel Dixon; Keith Norman; Paul Hellewell; Victoria Ridger
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

9.  Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis.

Authors:  R R Minter; E S Cohen; B Wang; M Liang; I Vainshtein; G Rees; L Eghobamien; P Harrison; D A Sims; C Matthews; T Wilkinson; P Monk; C Drinkwater; L Fabri; A Nash; M McCourt; L Jermutus; L Roskos; I K Anderson; M A Sleeman
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

10.  Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression.

Authors:  Elizabeth A Joyce; Stephen J Popper; Stanley Falkow
Journal:  BMC Genomics       Date:  2009-08-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.